CSE: FNDX | OTCQB: FDXTD | FSE: E8D0

Corporate Presentation

Who We Are

FendX is a technology company developing innovative solutions to help reduce the spread of harmful pathogesn in everyday environments. Leveraging proprietary technologies, FendX is advancing a portfolio of protective surface coatings, including a liquid-based surface coating and a specialized Foley catheter coating. FendX is also focused on developing an AI-powered app to detect microbial contamination on surfaces in real-time using a smart phone. FendX is focused on building a robust intellectual property portfolio and is committed to identifying and advancing new technologies and materials that enhance hygiene and safety across healthcare, consumer and commercial settings.

FendX Technologies Inc.

Facebook Linkedin

Surface Protection Coatings

Our Vision

Advancing innovative technologies to create products that contribute to enhancing hygiene and controlling pathogen spread.

Our Mission

To relentlessly innovate and develop surface protection solutions to make people's lives safer from the spread of pathogens.

Core Values

This tab is a default hidden tab.

Innovation: We foster a culture of continuous exploration, pushing the boundaries of nanotechnology to create groundbreaking solutions for infectious disease control.

Collaboration: We believe in the power of partnerships. By working together with researchers, manufacturers, and other experts, we amplify our impact.

Passion: We approach our work with unwavering enthusiasm and dedication. Our love for advancing nanotechnology and combating infectious diseases fuels our commitment to making a difference. passion propels us forward, even in the face of challenges.

Excellence: We strive for excellence in research, product development, and implementation. Quality is our hallmark.

Making a difference: We are driven by the belief that every action, no mater how small, contributes to positive change. We strive to leave a lasting impact on global health, one breakthrough at a time.

Hidden Threats In Everyday Places

  • Surfaces are major vectors for pathogen transmission¹
  • Healthcare-associated infections cost billions annually and cause thousands of deaths2,3
  • Existing cleaning methods are temporary, and can be toxic and ineffective4,5

 

Source1

Source2

Source3

Source4

Source5

Featured in the Media

An Introduction To FendX Nanotechnology

Open Media

FendX (OTC: FDXTF) Expands with New Tech and Partnerships (Produced by Allcap Research)

Open Media

Fendx Technologies Completes Pilot Manufacturing, Begins Real-World Testing of REPELWRAP Film

Open Media

One Nanotechnology Company Making The Future Safer? FendX Technologies CEO Interview (CSE:FNDX)

Open Media

“FendX Nanotechnology Innovations in Surface Protection …“

Open Media

Management & Board of Directors

Dr. Carolyn Myers MBA, PhD

President, CEO & Director

Rose Zanic CPA, CA

CFO & Corporate Secretary

Tash Yousuf BSc

Director of Nanotechnology Development and Operations

Stephen Randall CPA, CGA

Independent Board Member & Audit Committee Chair

Pierre Soulard B.C.L., LLB, LLM

Independent Board Member

Careers At FendX

Do you want to make a difference? Are you an innovative, collaborative and passionate leader?

Come join FendX, a company with career growth opportunities.

VIEW POSITIONS

Dr. Carolyn Myers MBA, PhD

President, CEO & Director
  • Principal of BioEnsemble LLC, assisting start-ups and small pharma companies in developing their business strategy and planning
  • Vice President International Business Development and Alliance Management at Allergan PLC (market cap $83 Bn, 2017, now Abbvie),
  • President of Dey Laboratories and President of Mylan Technologies Inc. (market cap $9.2 Bn, 2011, now Viatris Inc.)
  • Senior management at Pharmacia Corporation (now Pfizer)
  • Director Hyloris Pharmaceuticals SA (BR:HYL), EyeD Pharma (private)

Rose Zanic CPA, CA

CFO & Corporate Secretary
  • Over 25 years of capital markets and corporate finance expertise
  • Significant experience advising Canadian public companies with financing, M&A transactions and providing public company administration.
  • Previously Senior Vice-President, Corporate Finance at Wolverton Securities Ltd.
  • Experience as a director and/or officer with several Canadian publicly listed companies
  • Member of the TSX Venture Exchange BC Local Advisory Committee

Tash Yousuf BSc

Director of Nanotechnology Development and Operations
  • Expertise in project and operations management
  • Oversees business operations and product development, driving FendX’s key projects forward
  • Software Project Coordinator at Lenbrook International
  • Operations Manager at Cineplex VIP Cinemas

Dr. Carolyn Myers MBA, PhD

President, CEO & Director

Stephen Randall CPA, CGA

Independent Board Member & Audit Committee Chair
  • Senior financial manager and Director with over 40 years’ experience.
  • Served in senior financial roles with both private, publicly traded and start-up companies in the manufacturing, telecommunications, technology, and medical device sectors.
  • Former Board Member, CFO and Corporate Secretary of Titan Medical Inc (TSX: TMD and NASDAQ: TMDI)

Pierre Soulard B.C.L., LLB, LLM

Independent Board Member
  • Former Chief Legal Officer of CoinSmart (NEO: SMRT)
  • Former partner, at Miller Thomson, a leading Canadian law firm.
  • Focused on securities law, corporate finance, mergers and acquisitions and corporate governance for a wide range of national and international issuers and investors.